Di Chen

Di Chen


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in Small
Verified
Journal Article
Closed access
PDF file
SLShujing Lin
Shujing Lin
ZYZixian Yu
Zixian Yu
DCDi Chen
Di Chen
ZWZhigang Wang
Zhigang Wang
JMJianmin Miao
Jianmin Miao
DCDaxiang Cui
Daxiang Cui

1 January 2021 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
QLQichao Li
Qichao Li
DCDi Chen
Di Chen
JMJianmin Miao
Jianmin Miao
SLShujing Lin
Shujing Lin
ZYZixian Yu
Zixian Yu
XCXianping Chen
Xianping Chen

11 May 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
QLQichao Li
Qichao Li
DCDi Chen
Di Chen
JMJianmin Miao
Jianmin Miao
SLShujing Lin
Shujing Lin
ZYZixian Yu
Zixian Yu
ZAZhenghua An
Zhenghua An

1 March 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
SLShujing Lin
Shujing Lin
XZXiao Zhi
Xiao Zhi
DCDi Chen
Di Chen
FXFangfang Xia
Fangfang Xia
YSYihuan Shen
Yihuan Shen
Xianting DingXianting Ding
Xianting Ding

1 December 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
ZYZixian Yu
Zixian Yu
SLShujing Lin
Shujing Lin
FXFangfang Xia
Fangfang Xia
YLYanlei Liu
Yanlei Liu
DZDi Zhang
Di Zhang
DCDi Chen
Di Chen

10 December 2015 in Discover Nano
Verified
Journal Article
Open access
PDF file
YXYao Xie
Yao Xie
XZXiao Zhi
Xiao Zhi
HSHaichuan Su
Haichuan Su
KWKan Wang
Kan Wang
ZYZhen Yan
Zhen Yan
DCDaxiang Cui
Daxiang Cui
Early diagnosis is very important to improve the survival rate of patients with gastric cancer and to understand the biology of cancer. In order to meet the clinical demands for early diagnosis of gastric cancer, we developed a disposable easy-to-use electrochemical microfluidic chip combined with multiple antibodies against six kinds of biomarkers (carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), Helicobacter pylori CagA protein (H.P.), P53oncoprotein (P53), pepsinogen I (PG I), and PG-II). The six kinds of biomarkers related to gastric cancer can be detected sensitively and synchronously in a short time. The specially designed three electrodes system enables cross-contamination to be avoided effectively. The linear ranges of detection of the electrochemical microfluidic chip were as follows: 0.37–90 ng mL−1 for CEA, 10.75–172 U mL−1 for CA19-9, 10–160 U L−1 for H.P., 35–560 ng mL−1 for P53, 37.5–600 ng mL−1 for PG I, and 2.5–80 ng mL−1for PG II. This method owns better sensitivity compared with enzyme-linked immunosorbent assay (ELISA) results of 394 specimens of gastric cancer sera. Furthermore, we established a multi-index prediction model based on the six kinds of biomarkers for predicting risk of gastric cancer. In conclusion, the electrochemical microfluidic chip for detecting multiple biomarkers has great potential in applications such as early screening of gastric cancer patients, and therapeutic evaluation, and real-time dynamic monitoring the progress of gastric cancer in near future.